Multimodal Sexual Dysfunction Intervention In HCT

Completed · Not applicable

Conditions studied: Hematopoietic Stem Cell Transplantation, Hematologic Diseases, Sexual Dysfunction

In brief

This research study is evaluating the impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. It is expected that about 120 people who have undergone a stem cell transplant will take part in this research study.

Key facts

Study ID

NCT03803696

Run by

Massachusetts General Hospital

People needed

230

Starts

2019-02-01

Expected to finish

2025-12-31

Last updated by the study team

2026-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (≥ 18 years) with hematologic malignancy who underwent autologous or allogeneic HCT ≥ three months prior to study enrollment.
• Positive screen for sexual dysfunction that is causing distress based on the National Comprehensive Cancer Network (NCCN) survivorship guidelines
• Ability to read and respond to questions in English or to complete questionnaires with assistance from an interpreter.

You may not qualify if…

• Patients with relapsed disease requiring treatment
• Patients with a planned second transplant
• Patients > 5 years from their HCT
• Patients with psychiatric or cognitive conditions which the treating clinicians believes prohibits compliance with study procedures.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.